Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.07 CHF | +0.81% | +5.64% | +9.66% |
01:37pm | Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales | DJ |
10/05 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.66% | 21TCr | |
+29.98% | 68TCr | |
+30.34% | 57TCr | |
-3.52% | 36TCr | |
+18.59% | 33TCr | |
+4.07% | 28TCr | |
+16.21% | 24TCr | |
-6.83% | 20TCr | |
+7.09% | 17TCr | |
-1.22% | 16TCr |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Transcript : Novartis AG - Special Call